×
About 27,100 results

ALLMedicine™ Atopic Dermatitis Center

Research & Reviews  7,503 results

Allergic conjunctivitis: a risk factor for recurrent herpes simplex virus infections in...
https://doi.org/10.1684/ejd.2022.4333
European Journal of Dermatology : EJD; Salonen J, Remitz A et. al.

Dec 6th, 2022 - Patients with atopic dermatitis have an increased risk of herpes simplex virus (HSV) infections. We carried out a retrospective, cross-sectional study to investigate the association of disease severity, concomitant atopic diseases and filaggrin mu...

Prevalence of adult self-reported atopic dermatitis in Greece: results from a nationwid...
https://doi.org/10.1684/ejd.2022.4335
European Journal of Dermatology : EJD; Stefanou G, Gregoriou S et. al.

Dec 6th, 2022 - Atopic dermatitis (AD) is a common chronic inflammatory skin disorder. In Greece, there is a lack of data on AD epidemiology. The objective of the present study was to estimate the self-reported prevalence of AD and the prevalence of moderate/seve...

Atopic dermatitis refractory to dupilumab but markedly responsive to baricitinib
https://doi.org/10.1684/ejd.2022.4337
European Journal of Dermatology : EJD; Honda R, Suenaga A et. al.

Dec 6th, 2022 - Atopic dermatitis refractory to dupilumab but markedly responsive to baricitinib|2022|Honda R,Suenaga A,Nakahara T,Shibata-Kikuchi S,|

A cohort study of intrapartum group B streptococcus prophylaxis on atopic dermatitis in...
https://doi.org/10.1186/s12887-022-03758-5
BMC Pediatrics; Hong Z, Jing R et. al.

Dec 3rd, 2022 - To understand the occurrence of atopic dermatitis (AD) in children aged 2 years on exposure to maternal group B streptococcus (GBS) antibiotic prophylaxis (IAP). Retrospective cohort study of 2909 mother-child pairs. Taixing People's Hospital in E...

Disparities in the Diagnosis and Management of Anaphylaxis.
https://doi.org/10.1007/s11882-022-01053-y
Current Allergy and Asthma Reports; Trogen B, Jacobs S et. al.

Dec 2nd, 2022 - The goal of this review is to characterize health disparities impacting the recognition and treatment of anaphylaxis. Previous research has identified major health disparities related to atopic conditions including asthma, atopic dermatitis, and f...

see more →

Guidelines  10 results

English Version of Clinical Practice Guidelines for the Management of Atopic Dermatitis...
https://doi.org/10.1111/1346-8138.16527
The Journal of Dermatology; Saeki H, Ohya Y et. al.

Aug 23rd, 2022 - This is the English version of the Clinical Practice Guidelines for the Management of Atopic Dermatitis 2021. Atopic dermatitis (AD) is a disease characterized by relapsing eczema with pruritus as a primary lesion. In Japan, from the perspective o...

Updates on treatment guidelines for psoriasis, atopic dermatitis (eczema), hidradenitis...
https://www.ncbi.nlm.nih.gov/pubmed/33147660
Dermatology Online Journal; Yim RM, Singh I et. al.

Nov 5th, 2020 - Owing to the evolving COVID-19 pandemic and emerging data regarding immunosuppressant therapies for inflammatory cutaneous diseases, dermatologists are being encouraged to reevaluate their patients' treatment regimens to minimize any potential ris...

Considerations on biologicals for patients with allergic disease in times of the COVID-...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7300800
Allergy Vultaggio A, Agache I et. al.

Jun 6th, 2020 - The outbreak of the SARS-CoV-2-induced coronavirus disease 2019 (COVID-19) pandemic re-shaped doctor-patient interaction and challenged capacities of healthcare systems. It created many issues around the optimal and safest way to treat complex pat...

European task force on atopic dermatitis position paper: treatment of parental atopic d...
https://doi.org/10.1111/jdv.15709
Journal of the European Academy of Dermatology and Venere... Vestergaard C, Wollenberg A et. al.

Jun 25th, 2019 - Atopic dermatitis (AD) is a common inflammatory skin disease that affects both children and adults, including a large number of adults of reproductive age. Several guidelines for the treatment of AD exist, yet specific recommendations for the trea...

Consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) ...
https://doi.org/10.1111/jdv.14891
Journal of the European Academy of Dermatology and Venere... Wollenberg A, Barbarot S et. al.

Apr 21st, 2018 - This guideline was developed as a joint interdisciplinary European project, including physicians from all relevant disciplines as well as patients. It is a consensus-based guideline, taking available evidence from other guidelines, systematic revi...

see more →

Drugs  571 results see all →

Clinicaltrials.gov  1,065 results

B244 Topical Spray for the Treatment of Pruritus in Adults With a History of Atopic Dermatitis
https://clinicaltrials.gov/ct2/show/NCT04490109

Oct 14th, 2022 - This is a Prospective, Vehicle Controlled, Double-Blind, Multicenter, Randomized Phase II Trial, comparing the effect of twice daily B244 applications for 4 weeks vs vehicle applications on treatment of mild to moderate pruritus associated with at...

A Study to Assess the Efficacy and Safety of CMK389 in Patients With Moderate to Severe Atopic Dermatitis.
https://clinicaltrials.gov/ct2/show/NCT04836858

Oct 14th, 2022 - The main purpose of this phase 2 study is to assess the efficacy and safety of CMK389 in patients with atopic dermatitis.

Studies of Skin Microbes in Healthy People and in People With Skin Conditions
https://clinicaltrials.gov/ct2/show/NCT00605878

Oct 14th, 2022 - Skin microbiota (bacteria, fungi, viruses, phage, archae) play a significant role in common dermatological conditions, such as atopic dermatitis/AD (eczema). Since culture-dependent methods are often biased assessments of microbial diversity, geno...

Safety and Efficacy Study of EVO101 Topical Cream in Atopic Dermatitis
https://clinicaltrials.gov/ct2/show/NCT05579899

Oct 14th, 2022 - This is a Phase 2a safety and efficacy study of EVO101 Topical Cream, 0.1%, applied twice daily for 8 weeks in adults with mild-to moderate atopic dermatitis.

A Study To Learn About The Safety, Efficacy and Tolerability of PF-07038124 Ointment In Participants With Mild-To-Moderate Atopic Dermatitis Or Mild-To-Severe Plaque Psoriasis
https://clinicaltrials.gov/ct2/show/NCT05375955

Oct 14th, 2022 - The purpose of this clinical trial is to learn about how the safety, how well the study medicine works, extent to which side affects can be tolerated, and how the study medicine is changed and eliminated from your body after you apply it on your s...

see more →

News  1,647 results

Are Children With Atopic Dermatitis More Likely to Fracture Bones?
https://www.medscape.com/viewarticle/984999

Dec 5th, 2022 - Children with atopic dermatitis (AD) may be at increased risk for broken bones, results of a national cohort study in Korea suggest. "In this nationally representative cohort study, we observed that AD development was associated with an increased ...

Pooled Safety Data Analysis of Tralokinumab Reported
https://www.medscape.com/viewarticle/985050

Dec 5th, 2022 - The most comprehensive safety analysis of tralokinumab to date shows nothing unexpected in patients with atopic dermatitis (AD) treated for up to a year, according to a review published in the British Journal of Dermatology. Dr Eric Simpson These ...

Brepocitinib Improves Symptoms of Mild to Moderate AD in Phase 2b Trial
https://www.medscape.com/viewarticle/984697

Nov 28th, 2022 - Patients with mild to moderate atopic dermatitis (AD) who were treated with topical brepocitinib had a significant improvement in their Eczema Area and Severity Index score at 6 weeks compared with a group that received vehicle, in a recently publ...

EMA Recommends Limiting the Indications for JAK Inhibitors
https://www.medscape.com/viewarticle/984399

Nov 21st, 2022 - AMSTERDAM — In an effort to minimize the risk of serious side effects associated with Janus kinase (JAK) inhibitors, the Pharmacovigilance Risk Assessment Committee (PRAC) of the European Medicines Agency (EMA) has recommended limiting the indicat...

Arcutis Biotherapeutics' Skin Disease Cream Meets Main Goal in Late-Stage Study
https://www.medscape.com/viewarticle/984131

Nov 16th, 2022 - (Reuters) - Arcutis Biotherapeutics Inc said on Tuesday its skin cream met the main goal in a late-stage study for treating mild to moderate atopic dermatitis. The study was being conducted in adults and children six years and older. The cream rof...

see more →

Patient Education  44 results see all →